David C Linch (David Linch)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 5

Top Topics

Respiratory Failure

Diffuse Large B Cell Lymphoma

Top Venues

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

David C Linch, Robert K Hills, Alan K Burnett, Nigel H Russell, Rosemary E Gale
Therapy for isocitrate dehydrogenase 2 (IDH2)R172 -mutant acute myeloid leukaemia. British journal of haematology (2021)
David C Linch
Developments over the last 60 years in diffuse large B-cell lymphomas. British journal of haematology 191 (4) (2021)
Mary Gleeson, Nicholas Counsell, David Cunningham, Anthony Lawrie, Laura Clifton-Hadley, Eliza Hawkes, Andrew McMillan, Kirit M Ardeshna, Cathy Burton, Nick Chadwick, Joanna Gambell, Paul Smith, Paul Mouncey, Christopher Pocock, John Radford, John Davies, Deborah Turner, Anton Kruger, Peter Johnson, David C Linch
Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial. British journal of haematology 192 (6) (2020)
David C Linch, Robert K Hills, Alan K Burnett, Rosemary E Gale
The clinical impact of mutant DNMT3A R882 variant allele frequency in acute myeloid leukaemia. British journal of haematology 189 (3) (2020)
Elizabeth H Phillips, Catherine Burton, Amy A Kirkwood, Sharon Barrans, Anthony Lawrie, Simon Rule, Russell Patmore, Ruth Pettengell, Kirit M Ardeshna, Silvia Montoto, Shankara Paneesha, Laura Clifton-Hadley, David C Linch, Andrew K McMillan
Favourable outcomes for high-risk Burkitt lymphoma patients (IPI 3-5) treated with rituximab plus CODOX-M/IVAC: Results of a phase 2 UK NCRI trial. EJHaem 1 (1) (2020)